申请人:——
公开号:US20030225120A1
公开(公告)日:2003-12-04
This invention relates to novel dihydropyridine soft drugs of the formula &PHgr;OOR
1
, where &PHgr; is a dihydropyridine moiety. These compounds are useful as calcium channel antagonists with cardiovascular, antiasthmatic and antibroncho-constriction activity. Use of such soft drug analogs permits the administration of greater doses of the claimed dihydropyridine compounds without intolerable systemic effects. Thus, this invention also provides pharmaceutical compositions, as well as methods, for preventing and treating disorders such as hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders, while avoiding unwanted systemic effects.
本发明涉及一种新型二氢吡啶软药物,其化学式为&PHgr;OOR1,其中&PHgr;是二氢吡啶基团。这些化合物可用作钙通道拮抗剂,具有心血管、抗哮喘和抗支气管收缩活性。使用这样的软药物类似物允许以更大的剂量给予所述二氢吡啶化合物,而不会出现不可耐受的全身性影响。因此,本发明还提供了用于预防和治疗过敏、哮喘、支气管痉挛、痛经、食管痉挛、青光眼、早产、泌尿道疾病、胃肠运动障碍和心血管疾病等疾病的药物组合物,以及避免不必要的全身性影响的方法。